Performance Monitoring in Newborn Screening - a Co-ordinated National Approach
Wednesday, 21 September, 2016
Introduction
In January 2015, the NHS newborn blood spot screening programme was expanded to include four additional disorders. Six conditions are now screened for by MSMS; PKU, MCADD, GA1, MSUD, IVA and HCU. Nationally agreed screening protocols were adopted with specified analytical and clinical cut-offvalues (COV) so harmonisation between labs was important. To assist with performance monitoring and provide assurance of the efficacy of the screening programme, the national co-ordinating centre commissioned a team to collectand analyse population data and results from common IQC material from 14screening labs in England and Wales.
